Ehrenreich, H., Weissenborn, K., Begemann, M., Busch, M., Vieta i Pascual, E., & Miskowiak, K. W. (2020). Erythropoietin as candidate for supportive treatment of severe COVID-19.
Citação norma ChicagoEhrenreich, Hannelore, Karin Weissenborn, Martin Begemann, Markus Busch, Eduard Vieta i Pascual, y Kamilla W. Miskowiak. Erythropoietin As Candidate for Supportive Treatment of Severe COVID-19. 2020.
Citação norma MLAEhrenreich, Hannelore, et al. Erythropoietin As Candidate for Supportive Treatment of Severe COVID-19. 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.